These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 27538328)

  • 1. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
    Han F
    Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
    Ruoff C; Rye D
    Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypocretin system and narcolepsy].
    Arias-Carrión O
    Rev Med Chil; 2009 Sep; 137(9):1209-16. PubMed ID: 20011964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Narcolepsy with cataplexy: an autoimmune disease?].
    Jacob L; Dauvilliers Y
    Med Sci (Paris); 2014 Dec; 30(12):1136-43. PubMed ID: 25537044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brazilian guidelines for the diagnosis of narcolepsy].
    Alóe F; Alves RC; Araújo JF; Azevedo A; Bacelar A; Bezerra M; Bittencourt LR; Bustamante G; Cardoso TA; Eckeli AL; Fernandes RM; Goulart L; Pradella-Hallinan M; Hasan R; Sander HH; Pinto LR; Lopes MC; Minhoto GR; Moraes W; Moreira GA; Pachito D; Pedrazolli M; Poyares D; Prado L; Rizzo G; Rodrigues RN; Roitman I; Silva AB; Tavares SM
    Braz J Psychiatry; 2010 Sep; 32(3):294-304. PubMed ID: 20585744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Narcolepsy, from Westphal to hypocretin].
    Dauvilliers Y; Carlander B; Billiard M
    Presse Med; 2004 Dec; 33(22):1593-600. PubMed ID: 15685112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narcolepsy in adolescents.
    Sullivan SS
    Adolesc Med State Art Rev; 2010 Dec; 21(3):542-55, x-xi. PubMed ID: 21302860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Monaca C; Franco P; Philip P; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):25-31. PubMed ID: 27838095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy with cataplexy.
    Dauvilliers Y; Arnulf I; Mignot E
    Lancet; 2007 Feb; 369(9560):499-511. PubMed ID: 17292770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.